StageZero Life Sciences Ltd. ( SZLSF) - Key Metrics
SZLSF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0 | $0 | $0 | $0 |
| 2024Q2 | $0 | -$0.01 | $0 | $0 |
| 2024Q1 | $0 | $0 | $0 | $0 |
| 2023Q3 | $0.01 | -$0.01 | $0 | $0 |
| 2023Q2 | $0.01 | $0 | $0 | $0 |
SZLSF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | 0% | -3.03 |
| 2024Q2 | 0% | -0.57 |
| 2024Q1 | 0% | -3.23 |
| 2023Q3 | 0% | -1.51 |
| 2023Q2 | 0% | -3.50 |
SZLSF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q3 | 0.21% | 0% |
| 2024Q2 | -4.24% | 0% |
| 2024Q1 | -1.87% | 0% |
| 2023Q3 | 0.96% | 0% |
| 2023Q2 | 0.12% | 0% |
SZLSF
Price: $0
52 week price:
Earnings Per Share: -0.02 USD
Exchange: PNK
Sector: Healthcare
Industry: Diagnostics & Research
Market Capitalization: 123533